🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Human Immunodeficiency Virus (HIV)-1 Infection

Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health NCT06796686Phase 16 sites📍 San Francisco📍 Atlanta📍 Decatur National Institute of Allergy and Infectious Diseases (NIAI… · Tests: 426c.Mod.Core-C4b, HxB2.WT.Core-C4b, 3M-052-AF adjuvant, Aluminum hydroxide suspension (Alum) adjuvant, Diluent Analyses of Newly Diagnosed HIV Infection in Hong Kong NCT07725042n/a1 site📍 North Point Chinese University of Hong Kong Mass Balance and Absolute Oral Bioavailability of [14C]VH4524184 NCT07636928Phase 11 site📍 Groningen ViiV Healthcare · Tests: VH4524184, [14C]VH4524184 microdose, [14C]VH4524184 Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics NCT05674656Phase 1, Phase 28 sites📍 Long Beach📍 Washington D.C.📍 Fort Lauderdale ViiV Healthcare · Tests: Dolutegravir/Rilpivirine FDC Feasibility Study Comparing Use of One Or Two Probes for Thermal Ablation Among Screen Positive Women Living With HIV in C1001P-CS2 Kenya NCT07468695NA1 site📍 Nairobi Fred Hutchinson Cancer Center · Tests: Thermal ablation (TA) with 1 probe, Thermal ablation (TA) with 2 probes A Study to Investigate Cabotegravir for Neonates Exposed to HIV-1 NCT07275606Phase 1, Phase 21 site📍 Parow Valley ViiV Healthcare · Tests: Oral CAB, IM CAB LA First Time in Human Study of Long Acting VH4524184 Formulations NCT06310551Phase 13 sites📍 Lenexa📍 San Antonio📍 Salt Lake City ViiV Healthcare · Tests: Oral VH4524184, VH4524184 Formulation A SC, Placebo Formulation A SC, rHuPH20, VH4524184 Formulation B SC Efficacy and Safety of ACC017 Tablets Compared With Dolutegravir Sodium Tablets in Treatment-Naïve Adults With Human Immunodeficiency Virus Type 1 (HIV-1) NCT07711223Phase 1, Phase 21 site📍 Beijing Jiangsu Aidea Pharmaceutical Group Co., Ltd. · Tests: ACC017+FTC/TAF, DTG+FTC/TAF Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control Population NCT05580458Phase 1, Phase 21 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… · Tests: Shingrix Long-Acting Cabotegravir and Rilpivirine in People Living With HIV-1 Subtype A6: A Real-World Retrospective Study NCT07370649n/a7 sites📍 Prague📍 Frankfurt📍 Szczecin Pomeranian Medical University Szczecin · Tests: Cabotegravir Plus Rilpivirine Long-Acting Injectable Impacts of HIV Treatment Regimens on Archived Drug Resistance NCT07643948n/a1 site📍 Hong Kong Chinese University of Hong Kong One-stop PrEP Care Pathway to Simplify PrEP Delivery in Kenya: The One-Stop PrEP Care Project NCT05905640NA1 site📍 Kisumu University of Washington · Tests: Method of PrEP delivery and consultation Safety Study of MucoCept-CVN NCT07181486Phase 11 site📍 San Francisco Craig Cohen, MD, MPH · Tests: Live Biotherapeutic Product L. jensenii 1153-1666, Placebo A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIV NCT07392372Phase 16 sites📍 Chicago📍 Baltimore📍 St Louis BioNTech SE · Tests: BNT351, Placebo, BNT351, Placebo Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive WLWH in C1001P-CS9 South Africa NCT07645378NA1 site📍 Durban Fred Hutchinson Cancer Center · Tests: Thermal ablation (TA) with 1 probe, Thermal ablation (TA) with 2 probes A Study to Investigate Pharmacokinetics (PK), Safety, and Tolerability of VH4367310 in Healthy Adult Participants NCT07818915Phase 12 sites📍 Glendale📍 Baltimore ViiV Healthcare · Tests: VH4367310, Placebo Improving HIV Testing, Linkage, and Retention in Care for Men Through U=U Messaging NCT05602376NA2 sites📍 East London📍 Cape Town Desmond Tutu HIV Foundation · Tests: U=U testing messaging scripts, U=U adherence messaging scripts Finishing HIV Project NCT06406049NA1 site📍 Miami University of Miami · Tests: Control group-Standard Health Promotion, Social network intervention Study of GS-0415 and How It Works in People With HIV NCT07719491Phase 116 sites📍 Los Angeles📍 Washington D.C.📍 Miami Lakes Gilead Sciences · Tests: GS-0415, GS-0415 Placebo Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706 NCT06665646Phase 19 sites📍 San Francisco📍 Decatur📍 Boston National Institute of Allergy and Infectious Diseases (NIAI… · Tests: CD40.HIVRI.Env (VRIPRO), Hiltonol Poly-ICLC-adjuvant A Clinical Trial to Look at the Safety and Immune Responses of the RNA-based Vaccine BNT168 in Adults Living With or Without HIV NCT07698600Phase 14 sites📍 Houston📍 Johannesburg📍 Johannesburg BioNTech SE · Tests: BNT168, Placebo A Study to Assess the Safety, Tolerability, and Pharmacokinetics of VH4011499 Compared to Placebo in Adults Without HIV NCT06724640Phase 12 sites📍 Las Vegas📍 Austin ViiV Healthcare · Tests: VH4011499 low dose Injection, VH4011499 high dose Injection, Placebo Cardiovascular Risk in Children With Chronic Conditions Study NCT07086989n/a3 sites📍 Budapest📍 Budapest📍 Budapest Semmelweis University REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE NCT07476339Phase 410 sites📍 Clearwater📍 Ft. Pierce📍 Jacksonville CAN Community Health · Tests: Bictegravir, emtricitabine, and tenofovir alafenamide Prevention ICONA Dedicated Ensemble NCT07186244n/a53 sites📍 Chieti📍 Pescara📍 Bari Fondazione ICONA A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062) NCT07266831Phase 2, Phase 355 sites📍 Los Angeles📍 Denver📍 Washington D.C. Merck Sharp & Dohme LLC · Tests: ISL, ULO, BIC/FTC/TAF, Placebo for BIC/FTC/TAF, Placebo to ISL/ULO Feasibility Study Comparing One vs Two Probes for TA Among Cervical Cancer Screen Positive WLWH in C1001P-CS5 Rwanda NCT07390916NA1 site📍 Kigali Fred Hutchinson Cancer Center · Tests: Thermal ablation (TA) with 1 probe, Thermal ablation (TA) with 2 probes A Study to Investigate the Safety and PK of VH4770359 in Healthy Participants NCT07525544Phase 11 site📍 Baltimore ViiV Healthcare · Tests: VH4770359, Placebo, Midazolam HIV and Changes in the Gut Microbiome After Changes in Antiretroviral Therapy (ART) NCT06100211n/a1 site📍 Manchester University of Manchester BEYOND Study: Improving HIV Treatment and Well-Being Among Young MSM in Vietnam NCT07559266n/a1 site📍 Ho Chi Minh City Center for Applied Research on Men and Community Health, Vi… · Tests: NO interventions listed
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy